Influenza Vaccine Market Insights and Trends 2022-2026

Influenza Vaccine Market Overview

Influenza Vaccine typically known as flu shot and is used for protection against influenza virus. An influenza vaccine is a combination of three viruses types namely, influenza type A with H3N2 virus strain, influenza type A with H1N1 virus strain and influenza type B virus strain. Influenza is a contagious respiratory illness caused by influenza viruses, which may cause mild to severe illness.

Severity of the illness might land up to hospitalization or death. The risk of the serious flu complication is more in the age group such as older people, young children, and people with certain health conditions. It should be a habit to get vaccinated every year against this virus, as part of the best practice to avoid getting infected.

The categorization of this influenza virus is done into the mentioned categories, influenza A (H1N1) virus, an influenza A (H3N2) virus, and one or two influenza B viruses, depending on the flu vaccine. Patients show symptoms like chills, cough, sore throat, running nose, body aches, headache, fatigue, some cases people may have vomiting and diarrhea, this is commonly seen in children than adults. This flu is mostly spread through droplets from infected people, flu cough, sneeze or talks. A person’s eyes, mouth and nose are the entry channels through which the virus enters.

Infection can be spread by most healthy adults beginning 1 day before symptoms develop and up to 5 to 7 days after becoming sick. Once a person is symptomatic to the virus until onset, the span is 1 to 4 days, with an average of 2 days. For children and people with weak immune system; they might infect others even for a longer period of time.

The complication of virus may include bacterial pneumonia, ear infections, sinus infections, dehydration, and worsening of chronic medical conditions, such as congestive heart failure, asthma, or diabetes. Chronic medical condition may occur such as congestive heart failure, asthma, or diabetes.

Influenza Vaccine Market: Drivers and Restraints

The key drivers for seasonal influenza vaccines therapeutic market is increasing disease awareness on influenza caused by threat of pandemic influenza, wider vaccination coverage and rising government support for immunization against seasonal influenza. Also, the major market players have a great pipeline products, thus making a strong product portfolio.

The major restrains of this market are variable demand, limited production capacity, a high level of required investment, and strict regulations present barriers to new entrants.

Influenza Vaccine Market: Regional Overview

The geographical market of seasonal influenza vaccines is spread across Japan, Australia, New Zealand, China, Taiwan, Philippines, Hong Kong, Malaysia, India and Singapore. The seasonal influenza vaccine market across the seven major markets (7MM) of the US, France, Germany, Italy, Spain, the UK, and Japan, was projected to rise from $3.1 billion in 2015 to $4.3 billion by 2025, at a compound annual growth rate of 3.3%.

Philippines' seasonal influenza vaccine market is the most attractive for Asia-Pacific region both in terms of value and growth rate; other attractive markets in terms of growth rate are Malaysia and Singapore. Australia's seasonal influenza vaccine market is one amongst the large sized attractive market forecast to grow at a healthy growth rate during the period 2011–2018.

Influenza Vaccine Market: Key Players

The key players in this market include GlaxoSmithKline, Novartis, CSL, MedImmune, Sanofi-Pasteur, Solvay, Sinovac Biotech and Hualun Biologicals. Some of the other market players are ID Biomedical Corp. of Quebec (distributed by GlaxoSmithKline), Seqirus, Protein Sciences, MedImmune, etc.

Influenza Vaccine Market: Segmentation

The major segmentation of the vaccine market can be done under three major headers mentioned as end users, treatment type and geographical segmentation.

Based on the end users, it can further sub-segmented as following:

  • Paediatrics
  • Adolescence
  • Adults
  • Elderly

These end users influence the market through different channels of administration of the vaccines. The channels like clinics, hospitals, mail service, prisons, universities, retail service, combined retail, etc.

Treatment of seasonal influenza is dominated by two categories of treatment options, vaccines and antiviral therapies. The categorization of this influenza virus is done into the mentioned categories, influenza A (H3N2) virus, an influenza A (H3N2) virus, and one or two influenza B viruses, depending on the flu vaccine.

The third major segmentation category is the geographical segmentation. This would depend upon the geographical market which is most flouring for the given vaccine market.

Click to View Full Report@ https://www.futuremarketinsights.com/reports/seasonal-influenza-vaccines-therapeutics-market

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasoun...
Read more

Global Medical face shield Market Insights and Outlook 2022-2032

Image
Medical face shield can become as ubiquitous as masks, as new findings on the airborne spread of Covid-19 influence behavior and guidelines. According to a latest study by Future Market Insights,  Medical Face Shields Market  will grow at over 11% CAGR through 2030. Medical face shields have proven to be an effective first-line defence against airborne diseases such as Zika, SARS, Ebola, flu, and now Covid-19. As a result, increased adoption of medical face shields, and thus increased production, is expected to drive the market during the forecast period. The IDSA (Infectious Diseases Society of America) has included the use of PPE (Personal Protective Equipment) such as face shields and masks in its recommendations. Though masks have been widely used throughout the world, their effectiveness is not widely known. The possibility of cloth masks providing marginal virus protection due to potential moisture retention, poor filtration, and re-use cannot be ruled out. Face ...
Read more

Aesthetic Medical Devices Market 2022-2032: Advanced R&D Process Strategies

Image
A recently published study by FMI expects the global  Aesthetic Medical Devices Market  to augment at a 9.6% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 35000 Million is expected for the market. The increase may be attributed mostly to the increased development of technologically advanced and user-friendly devices, as well as the rising desire for cosmetic treatments among individuals. In addition to that, the popularity of minimally invasive and non-invasive aesthetic operations is expanding internationally as a result of loose facial skin, particularly around the eyes, jowls, and cheeks; and dry or roughened skin, among other important changes that occur as a person ages. Furthermore, the demand for aesthetic devices is rising due to the growing popularity of cosmetic operations among those seeking to improve their looks and stand out from the crowd. Key Takeaways from the Market Study FMI projects the global aesthetic ...
Read more